 Connection
Geoffrey Nunns to Combined Modality Therapy
This is a "connection" page, showing publications Geoffrey Nunns has written about Combined Modality Therapy.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.131 |
|
|
|
-
Wach MM, Bank H, Kelly K, Le T, Derby J, Nunns G, Zureikat AH, Bartlett DL, Ahrendt SA, Pingpank JF, Choudry HA, Ongchin M. A Retrospective Examination of Neoadjuvant Chemotherapy for Metachronous Colorectal Peritoneal Metastases Prior to CRS/HIPEC. Ann Surg Oncol. 2026 Jul; 33(7):6175-6184.
Score: 0.047
-
Hamed AB, El Asmar R, Tirukkovalur N, Tcharni A, Tatsuoka C, Jelinek M, Derby J, Dubrovsky G, Nunns G, Ongchin M, Pingpank JF, Zureikat AH, Bartlett DL, Singhi A, Choudry MH, AlMasri SS. Insight into Predictors of Cytoreduction Score Following Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy for Gastric Peritoneal Carcinomatosis Improves Patient Selection and Prognostic Outcomes. Ann Surg Oncol. 2025 Jan; 32(1):199-208.
Score: 0.043
-
Wach MM, Nunns G, Hamed A, Derby J, Jelinek M, Tatsuoka C, Holtzman MP, Zureikat AH, Bartlett DL, Ahrendt SA, Pingpank JF, Choudry MHA, Ongchin M. Normal CEA Levels After Neoadjuvant Chemotherapy and Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion Predict Improved Survival from Colorectal Peritoneal Metastases. Ann Surg Oncol. 2024 Apr; 31(4):2391-2400.
Score: 0.041
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|